Cargando…
Lack of Epileptogenic Effects of the Creatine Precursor Guanidinoacetic Acid on Neuronal Cultures In Vitro
The creatine precursor Guanidinoacetic Acid (GAA) accumulates in the genetic deficiency of the GuanidinoAcetate Methyl Transferase (GAMT) enzyme and it is believed to cause the seizures that often occur in this condition. However, evidence that it is indeed epileptogenic is scarce and we previously...
Autores principales: | Poggio, Fabio, Brofiga, Martina, Tedesco, Mariateresa, Massobrio, Paolo, Adriano, Enrico, Balestrino, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856136/ https://www.ncbi.nlm.nih.gov/pubmed/36671459 http://dx.doi.org/10.3390/biom13010074 |
Ejemplares similares
-
Modularity and neuronal heterogeneity: Two properties that influence in vitro neuropharmacological experiments
por: Brofiga, Martina, et al.
Publicado: (2023) -
Effects of Delivering Guanidinoacetic Acid or Its Prodrug to the Neural Tissue: Possible Relevance for Creatine Transporter Deficiency
por: Adriano, Enrico, et al.
Publicado: (2022) -
Processing mechanism of guanidinoacetate in choroid plexus epithelial cells: conversion of guanidinoacetate to creatine via guanidinoacetate N-methyltransferase and monocarboxylate transporter 12-mediated creatine release into the CSF
por: Jomura, Ryuta, et al.
Publicado: (2022) -
Creatine, guanidinoacetate and homoarginine in statin-induced myopathy
por: Neu, Axel, et al.
Publicado: (2020) -
Creatine as a Candidate to Prevent Statin Myopathy
por: Balestrino, Maurizio, et al.
Publicado: (2019)